Your browser doesn't support javascript.
loading
FOXA1 Reprogramming Dictates Retinoid X Receptor Response in ESR1-Mutant Breast Cancer.
Wu, Yang; Li, Zheqi; Wedn, Abdalla M; Casey, Allison N; Brown, Daniel; Rao, Shalini V; Omarjee, Soleilmane; Hooda, Jagmohan; Carroll, Jason S; Gertz, Jason; Atkinson, Jennifer M; Lee, Adrian V; Oesterreich, Steffi.
Afiliación
  • Wu Y; School of Medicine, Tsinghua University, Beijing, China.
  • Li Z; Women's Cancer Research Center, UPMC Hillman Cancer Center, Magee-Women's Research Institute, Pittsburgh, Pennsylvania.
  • Wedn AM; Women's Cancer Research Center, UPMC Hillman Cancer Center, Magee-Women's Research Institute, Pittsburgh, Pennsylvania.
  • Casey AN; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Brown D; Women's Cancer Research Center, UPMC Hillman Cancer Center, Magee-Women's Research Institute, Pittsburgh, Pennsylvania.
  • Rao SV; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Omarjee S; Women's Cancer Research Center, UPMC Hillman Cancer Center, Magee-Women's Research Institute, Pittsburgh, Pennsylvania.
  • Hooda J; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Carroll JS; Institute for Precision Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Gertz J; Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Atkinson JM; Cancer Research UK, Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
  • Lee AV; Women's Cancer Research Center, UPMC Hillman Cancer Center, Magee-Women's Research Institute, Pittsburgh, Pennsylvania.
  • Oesterreich S; Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, Pennsylvania.
Mol Cancer Res ; 21(6): 591-604, 2023 06 01.
Article en En | MEDLINE | ID: mdl-36930833

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor alfa de Estrógeno / Factor Nuclear 3-alfa del Hepatocito Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Mol Cancer Res Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Receptor alfa de Estrógeno / Factor Nuclear 3-alfa del Hepatocito Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Mol Cancer Res Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China